Correlation Between Rigel Pharmaceuticals and Solid Biosciences
Can any of the company-specific risk be diversified away by investing in both Rigel Pharmaceuticals and Solid Biosciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Rigel Pharmaceuticals and Solid Biosciences into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Rigel Pharmaceuticals and Solid Biosciences LLC, you can compare the effects of market volatilities on Rigel Pharmaceuticals and Solid Biosciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Rigel Pharmaceuticals with a short position of Solid Biosciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of Rigel Pharmaceuticals and Solid Biosciences.
Diversification Opportunities for Rigel Pharmaceuticals and Solid Biosciences
-0.28 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Rigel and Solid is -0.28. Overlapping area represents the amount of risk that can be diversified away by holding Rigel Pharmaceuticals and Solid Biosciences LLC in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Solid Biosciences LLC and Rigel Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Rigel Pharmaceuticals are associated (or correlated) with Solid Biosciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Solid Biosciences LLC has no effect on the direction of Rigel Pharmaceuticals i.e., Rigel Pharmaceuticals and Solid Biosciences go up and down completely randomly.
Pair Corralation between Rigel Pharmaceuticals and Solid Biosciences
Given the investment horizon of 90 days Rigel Pharmaceuticals is expected to generate 1.05 times more return on investment than Solid Biosciences. However, Rigel Pharmaceuticals is 1.05 times more volatile than Solid Biosciences LLC. It trades about 0.04 of its potential returns per unit of risk. Solid Biosciences LLC is currently generating about -0.09 per unit of risk. If you would invest 3,346 in Rigel Pharmaceuticals on August 11, 2025 and sell it today you would earn a total of 173.00 from holding Rigel Pharmaceuticals or generate 5.17% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Rigel Pharmaceuticals vs. Solid Biosciences LLC
Performance |
| Timeline |
| Rigel Pharmaceuticals |
| Solid Biosciences LLC |
Rigel Pharmaceuticals and Solid Biosciences Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Rigel Pharmaceuticals and Solid Biosciences
The main advantage of trading using opposite Rigel Pharmaceuticals and Solid Biosciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Rigel Pharmaceuticals position performs unexpectedly, Solid Biosciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Solid Biosciences will offset losses from the drop in Solid Biosciences' long position.| Rigel Pharmaceuticals vs. Gossamer Bio | Rigel Pharmaceuticals vs. Kalvista Pharmaceuticals | Rigel Pharmaceuticals vs. Prothena plc | Rigel Pharmaceuticals vs. Ventyx Biosciences |
| Solid Biosciences vs. Autolus Therapeutics | Solid Biosciences vs. QuantumSi | Solid Biosciences vs. Rocket Pharmaceuticals | Solid Biosciences vs. LB Pharmaceuticals Common |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bond Analysis module to evaluate and analyze corporate bonds as a potential investment for your portfolios..
Other Complementary Tools
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account |